Clinical implications of cytomegalovirus in glioblastoma progression and therapy

Abstract Glioblastoma (GBM) is one of the deadliest brain cancers with a median survival of only 15 months. This poor prognosis has prompted exploration of novel therapeutic targets for GBM patients. Human cytomegalovirus (HCMV) has been implicated in GBM; however, its impact remains poorly defined,...

Full description

Bibliographic Details

Published in:	npj Precision Oncology
Main Authors:	Noe B. Mercado, Jacqueline N. Real, Jacob Kaiserman, Eleni Panagioti, Charles H. Cook, Sean E. Lawler
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-09-01
Online Access:	https://doi.org/10.1038/s41698-024-00709-4